Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Time Partners is a UK-based specialist merchant banking and private markets advisory firm rather than a drug developer or healthcare operating company. The firm advises investors, families, institutions, founders, and privately owned businesses on long-term investment strategies, private markets programs, and corporate finance matters. While it has been involved in life-science investing through its role as investment adviser to Time Boost Capital, a genomics-focused venture fund associated with Illumina accelerator programs, Time Partners itself does not appear to develop therapeutics, diagnostics, or healthcare products. Its activities span investment advice, strategic advice, capital raising, restructurings, acquisitions and disposals, and investment vehicle design. For a biotech analyst, the key point is that Time Partners is an active financial/advisory firm with exposure to life sciences investing, not a biotech or pharma company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Time Partners.